Final answer:
1. true Naloxone is a correct treatment for infants with respiratory depression caused by maternal opioid use, as it's an opiate antagonist that reverses narcotic effects.
Step-by-step explanation:
True, naloxone is an appropriate treatment for infants displaying signs of respiratory depression due to the mother's opioid narcotic administration prior to delivery. Naloxone is an opiate antagonist that rapidly reverses the effects of narcotics, including respiratory depression that follows acute narcotic intoxication. It is important to note that naloxone has a short duration of action and must be administered via a parenteral route, emphasizing the need for medical supervision when treating opioid-induced respiratory depression in newborns.
The statement is true. If a mother has been administered opioid narcotics prior to delivery and the infant is displaying signs of respiratory depression, naloxone is an appropriate treatment. Naloxone is an opiate antagonist that reverses the respiratory depression caused by opioid intoxication in newborns. It works by antagonizing the actions of opioids at their receptors and helps to keep the infant breathing until further medical treatment can be provided.